Center for Endoscopic Research and Therapeutics, Section of Gastroenterology, Department of Medicine;
J Gastrointest Oncol. 2012 Dec;3(4):314-21. doi: 10.3978/j.issn.2078-6891.2012.038.
Endoscopic ultrasound (EUS) is considered the most accurate tool for the TNM staging of esophageal cancer, but its role in early Barrett's neoplasia is still debatable. The aim was to evaluate the utility of EUS in Barrett's patients prior to therapy. Retrospective review of 109 patients enrolled in a treatment protocol for Barrett's neoplasia in our institution. EUS assessment was classified as suspicious for invasion in 19 patients; 84% of them had no evidence of invasion in final pathology. The assessment of depth of invasion of Barrett's neoplasia based solely on EUS findings leads to overstaging in most patients.
内镜超声（EUS）被认为是食管癌 TNM 分期最准确的工具，但在早期 Barrett 肿瘤中的作用仍存在争议。本研究旨在评估 EUS 在 Barrett 患者治疗前的应用价值。回顾性分析了我院 Barrett 肿瘤治疗方案中纳入的 109 例患者。19 例患者 EUS 评估提示有侵犯可能；其中 84%的患者最终病理未见侵犯。单纯基于 EUS 检查结果评估 Barrett 肿瘤的侵犯深度会导致大多数患者过度分期。
